Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference

Oncogene

Volumn 21, Issue 39, 2002, Pages 6041-6048

  Jiang, Ming ^a   Milner, Jo ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

HPV16; Human cervical cancer; RNA interference

Indexed keywords

VIRUS RNA;

ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA DEGRADATION; UTERINE CERVIX CARCINOMA; VIRUS GENE; WART VIRUS;

ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA PRIMERS; FEMALE; GENE EXPRESSION; GENE SILENCING; GENES, VIRAL; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHOSPHORYLATION; REPRESSOR PROTEINS; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; RNA, UNTRANSLATED; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; MAMMALIA; PAPILLOMAVIRUS; PAPOVAVIRIDAE;

EID: 0037026601     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205878     Document Type: Article

References (30)

1. Aguilar-Lemarroy A, Gariglio P, Whitaker NJ, Eichhorst ST, zur Hausen H, Kramer PH and Rosl F. (2002). Oncogene, 21, 165-175.
2. Baker CC, Phelps WC, Lindgren V, Braun M J, Gonda MA and Howley PM. (1987). J. Virology, 61, 962-971.
3. Butz K, Shahabeddin L, Geisen C, Spitkovsky D, Ullmann A and Hoppe-Seyler F. (1995). Oncogene, 10, 927-936.
4. Butz K, Geisen C, Ullmann A, Spitkovsky D and Hoppe-Seyler F. (1996). Int. J. Cancer, 68, 506-513.
5. Caplen NJ, Parrish S, Imani F, Fire A and Morgan RA. (2001). Proc. Natl. Acad. Sci. USA, 98, 9742-9747.
6. Carthew RW. (2001). Curr. Opin. Biol., 13, 244-248.
7. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T. (2001). Nature, 411, 428-429.
8. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE and Mello CC. (1998). Nature, 391, 806-811.
9. Gu W, Pan F, Zhang H, Bassell GJ and Singer RH. (2002). J. Cell Biol., 156, 41-51.
10. Hengstermann A, Linares LK, Ciechanover A, Whitaker NJ and Scheffner M. (2001). Proc. Natl. Acad. Sci. USA, 98, 1218-1223.
11. Hietenan S, Lain S, Krausz E, Blattner C and Lane DL. (2000). Proc. Natl. Acad. Sci. USA, 97, 8501-8506.
12. Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ and Plasterk RH. (2001). Genes Dev., 15, 2654-2659.
13. Knight SW and Bass BL. (2001). Science, 293, 2269-2271.
14. Koromilas AE, Li S and Matlashewski G. (2001). Cytokine Growth Factor Rev., 12, 157-170.
15. Levine AJ. (1997). Cell, 88, 323-331.
16. Lipardi C, Wei Q and Paterson BM. (2001). Cell, 107, 297-307.
17. McMurray HR, Nguyen D, Westbrook TF and McAnce DJ. (2001). Int. J. Exp. Pathol., 82, 15-33.
18. Mosner J, Mummenbrauer T, Brauer C, Sczakiel G, Grosse F and Deppert W. (1995). EMBO J., 14, 4442-4449.
19. Novina CD, Murray FM, Dykxhoorn DM, Beresford PJ, Reiss J, Lee S-K, Collman RG, Lieberman J, Shankar P and Sharp PA. (2002). Nature Med., 8, 681-686.
20. Nykanen A, Haley B and Zamore PD. (2001). Cell, 107, 309-321.
21. Orphanides G and Reinberg D. (2002). Cell, 108, 439-451.
22. Patel D, Huang SM, Baglia LA and McCance DJ. (1999). EMBO J., 18, 5061-5072.
23. Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM. (1990). Cell, 63, 1129-1136.
24. Scheffner M, Münger K, Byrne JC and Howley PM. (1991). Proc. Natl. Acad. Sci. USA, 88, 5523-5527.
25. Scheffner M, Huibregtse JM, Vierstra RD and Howley PM. (1993). Cell, 75, 495-505.
26. Sharp PA. (2001). Genes Dev., 15, 485-490.
27. Steele C, Cowsert LM and Shillitoe EJ. (1993). Cancer Res., 53, 2330-2337.
28. Thomas M, Pim D and Banks L. (1999). Oncogene, 18, 7690-7700.
29. Zamore PD, Tuschl T, Sharp PA and Bartel DP. (2000). Cell, 101, 25-33.
30. zur Hausen H. (2000). J. Natl. Cancer Inst., 92, 690-698.